New hope in fight against malaria

2014-05-26 12:21


Multimedia   ·   User Galleries   ·   News in Pictures Send us your pictures  ·  Send us your stories

Washington - Scientists seeking a vaccine against malaria, which kills a child every minute in Africa, have developed a promising new approach intended to imprison the disease-causing parasites inside the red blood cells they infect.

The researchers said on Thursday an experimental vaccine based on this idea protected mice in five trials and will be tested on lab monkeys beginning in the next four to six weeks.

Dr Jonathan Kurtis, director of Rhode Island hospital's centre for international health research, said if the monkey trials go well, a so-called Phase I clinical trial testing the vaccine in a small group of people could begin within a year and a half.

Using blood samples and epidemiological data collected from hundreds of children in Tanzania, where malaria is endemic, by doctors including Patrick Duffy and Michal Fried of the US national institutes of health, the researchers pinpointed a protein, dubbed PfSEA-1, that the parasites need in order to escape from inside red blood cells they infect as they cause malaria.

The researchers then found that antibodies sent by the body's immune system to take action against this protein managed to trap the parasites inside the red blood cells, blocking the progression of the disease.

Scientists have struggled for years to create an effective vaccine against malaria, a mosquito-borne disease that the UN, World Health Organisation estimates kills 627 000 people a year, mostly children in sub-Saharan Africa.

'A burning house'

"It's profoundly important to develop an effective malaria vaccine", said Dr Anthony Fauci, director of the NIH's national institute of allergy and infectious diseases, calling the study "a novel and different type of an approach toward a vaccine".

"Since the malaria parasite has such a complex replication cycle, there are multiple points in that replication cycle that are vulnerable to interference by an antibody or some response that can be induced by a vaccine", Fauci said.

Microscopic malaria parasites are carried in the saliva of female mosquitoes and enter a person's bloodstream through the insect's bite. The parasites pass through the liver and infect red blood cells.

They replicate wildly in these cells and cause them to rupture, flooding the body with more and more parasites.

Two existing approaches to vaccine development have sought to block the parasites from entering the liver or red blood cells. The new approach instead tries to bottle them up inside the red blood cells, or, as Kurtis put it, "trap them inside a burning house".

If the parasites remain trapped, they can be harmlessly gobbled up in the spleen by immune system cells called macrophages, Kurtis said.

The researchers developed a vaccine that targeted PfSEA-1 and tried it on mice. In five experiments, vaccinated mice that were exposed to malaria had parasite levels four times lower than unvaccinated mice and survived twice as long afterward.

The researchers then looked at blood samples from some of the Tanzanian children. Roughly one in 20 had naturally occurring levels of the antibodies that target PfSEA-1, and among these children there were no cases of severe malaria.

The researchers also examined blood samples from 138 boys and men from a malaria-endemic area of Kenya. Those with detectable levels of naturally occurring antibodies to PfSEA-1 had 50% lower parasite levels than those who did not.

Kurtis expressed hope about the prospects of a vaccine targeting this protein, but said the best future vaccine likely would combine this approach with others to attack the parasite on several fronts. He noted that there is currently no licensed vaccine for human parasitic infection.
Read more on:    us  |  insects  |  health  |  research

Join the conversation! encourages commentary submitted via MyNews24. Contributions of 200 words or more will be considered for publication.

We reserve editorial discretion to decide what will be published.
Read our comments policy for guidelines on contributions. publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
Comments have been closed for this article.

Inside News24


Book flights

Compare, Book, Fly

Traffic Alerts
There are new stories on the homepage. Click here to see them.


Create Profile

Creating your profile will enable you to submit photos and stories to get published on News24.

Please provide a username for your profile page:

This username must be unique, cannot be edited and will be used in the URL to your profile page across the entire network.


Location Settings

News24 allows you to edit the display of certain components based on a location. If you wish to personalise the page based on your preferences, please select a location for each component and click "Submit" in order for the changes to take affect.

Facebook Sign-In

Hi News addict,

Join the News24 Community to be involved in breaking the news.

Log in with Facebook to comment and personalise news, weather and listings.